{"transactions":[{"id":3283724,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2026-09-08T12:31:48.000Z","date":"2026-08-28","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments."}],"balance_after":35000,"derivative":{"exercise_price":1.77,"expiration_date":"2036-08-27","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001971798-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1971798/000197179826000005/primary_doc.xml","form_type":"4"}},{"id":3283723,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-08T12:31:48.000Z","date":"2026-08-27","kind":"purchase","planned":false,"acquired":true,"shares":33333,"price":2.01,"value":66999.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $2.00 and $2.017 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":199999,"source":{"system":"sec-edgar","filing":"0001971798-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971798/000197179826000005/primary_doc.xml","form_type":"4"}},{"id":866996,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2026-03-03T13:49:19.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% will vest on March 1, 2027, and the remaining 75% will vest in 12 equal installments on the last day of each quarter beginning on March 31, 2027."}],"balance_after":500000,"derivative":{"exercise_price":0.6704,"expiration_date":"2036-02-29","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001971798-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000197179826000002/primary_doc.xml","form_type":"4"}},{"id":866995,"issuer":{"id":7808,"kind":"organization","name":"NEUROONE MEDICAL TECHNOLOGIES Corp","symbol":"NMTC"},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-03T13:49:19.000Z","date":"2026-03-01","kind":"purchase","planned":false,"acquired":true,"shares":1000000,"price":0.6704,"value":670400.0,"ownership":{"direct":true},"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001971798-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1500198/000197179826000002/primary_doc.xml","form_type":"4"}},{"id":1124623,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"officer":true,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:19:13.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2026 with the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2026."}],"balance_after":250000,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001437749-25-019296","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019296/rdgdoc.xml","form_type":"4"}},{"id":1494978,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T21:06:14.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025."}],"balance_after":130000,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001235802-24-000053","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000053/primary_doc.xml","form_type":"4"}},{"id":1738913,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-11-16T21:37:28.000Z","date":"2023-11-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.46,"value":49200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $2.42 to $2.49, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":527114,"source":{"system":"sec-edgar","filing":"0001235802-23-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000111/primary_doc.xml","form_type":"4"}},{"id":1844117,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:14:23.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":38364,"price":3.91,"value":150003.24,"ownership":{"direct":true},"balance_after":507114,"source":{"system":"sec-edgar","filing":"0001235802-23-000069","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000069/primary_doc.xml","form_type":"4"}},{"id":1921688,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-11T21:40:11.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests with respect to 35,000 common shares on April 10, 2024 and with respect to the remaining 75% of the common shares in 12 as nearly equal as possible quarterly installments commencing three months after the one-year anniversary of the grant date."}],"balance_after":140000,"derivative":{"exercise_price":1.57,"expiration_date":"2033-04-09","underlying":"Common Shares","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001235802-23-000040","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000040/primary_doc.xml","form_type":"4"}},{"id":1921687,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":63299,"kind":"person","name":"Wambeke David J.","position":1,"cik":"0001971798","reported_name":"Wambeke David J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-04-11T21:40:11.000Z","date":"2023-04-10","kind":"purchase","planned":false,"acquired":true,"shares":468750,"price":1.6,"value":750000.0,"ownership":{"direct":true},"balance_after":468750,"source":{"system":"sec-edgar","filing":"0001235802-23-000040","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000040/primary_doc.xml","form_type":"4"}}]}